# TScan Therapeutics Q3 Revenue Falls 76.7% to $586,000

By John Kim

Canonical URL: https://www.tokenpost.com/news/business/55674
Published: 2026-11-12T17:10:14.000Z
Updated: 2026-11-12T17:10:14.000Z
Section: Business

> The company recorded a GAAP loss of $0.25 per share for the quarter.

TScan Therapeutics, Inc. posted $586,000 in revenue for the third quarter, down 76.7% from a year earlier, while it recorded a GAAP loss of $0.25 per share.

Revenue in the year-earlier quarter was $2.511 million.